Rate my stack - suffering from male pattern baldness
    7/4/2026

    From the encyclopedia
    Minoxidil β†’

    An essential vasodilator with some anti-androgenic effects

    Finasteride β†’

    Frontline, gold standard treatment for combatting androgenic alopecia

    At a glance
    In this hair loss treatment regimen post, the primary subjects mentioned are
    πŸ’Š Minoxidil (oral) 2.5mg ED
    πŸ’Š Finasteride (oral) 1mg ED
    πŸ’§ AHK-Cu solution (topical) 1%
    πŸ’§ GHK-Cu solution (topical) 1%
    πŸ’§ The Ordinary Hair serum (topical)
    πŸ’§ Ketoconazole shampoo (topical) 2% twice a week
    πŸ’Š Vitamin D3 (oral) 5000IU 2-3 years
    πŸ’Š Vitamin K2 (oral) 125mcg
    πŸ’Š Zinc Glycinate (oral) 20mg
    πŸ’Š Magnesium Glycinate (oral) 300mg 2-3 years
    β€’ Microneedling once a week
    πŸ’§ RU58841 (topical) 5%
    the tone is 😐 neutral.

    Other terms

    A 22-year-old male is using a combination of oral Minoxidil, Finasteride, topical solutions, and supplements to combat male pattern baldness, with plans to add RU58841. Some users suggest adding treatments targeting androgen receptors and question the necessity of certain supplements.
    View this post in the Community β†’

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results
      The Modern Treatment of Androgenetic Alopecia

      research Π’Ρ–Π΅ Modern treatment of androgenetic alopecia

      February 2017 in “Vestnik dermatologii i venerologii”
      This review examines the molecular mechanisms and current treatment options for androgenetic alopecia, highlighting potential future therapies but providing no new experimental findings.
      Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      research Antiandrogens and Androgen Inhibitors

      November 2020 in “Elsevier eBooks”
      This source outlines various antiandrogen and androgen inhibitor drugs used to treat cutaneous disorders of hyperandrogenism, detailing their mechanisms, uses, dosages, and side effects, with emphasis on spironolactone, finasteride, dutasteride, and oral contraceptives.
      Alopecia: The Search for Novel Agents Continues

      research Alopecia - the search for novel agents continues

      11 citations , August 1997 in “Expert Opinion on Therapeutic Patents”
      This review discusses nearly 70 patent applications for the treatment of androgenetic alopecia and other hair conditions, highlighting the mechanisms of action explored but reports no clinical results.
      Male Androgenetic Alopecia

      research Male androgenetic alopecia

      54 citations , July 2002 in “Clinical and Experimental Dermatology”
      This article provides a critical overview of recent discoveries in the genetics and molecular processes involved in androgenetic alopecia, focusing on its polygenic basis and DHT dependency, but reports no new clinical results.